PER 2.44% 8.0¢ percheron therapeutics limited

Ann: ANP meeting with US FDA granted for ATL1102 in DMD, page-76

  1. 3,141 Posts.
    lightbulb Created with Sketch. 534
    Not much. Time delays maybe.

    our inflammation targeting drug can be used alongside any other einstein dmd drug that may (impossibly) pop up from now here. so competion isnt a threat, if theres any left...

    we dont know what happens to kids after 6++ to 12 + months of dosing. Very very unlikely (someone correct me) but i guess if we havent dosed for 12+ months the drug could be less effective. Wear off so to speak but im just searching for any possible miniscule negative so... nothing can go wrong. Imo
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
-0.002(2.44%)
Mkt cap ! $72.12M
Open High Low Value Volume
8.1¢ 8.1¢ 8.0¢ $3.675K 45.89K

Buyers (Bids)

No. Vol. Price($)
1 343 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 10000 1
View Market Depth
Last trade - 14.33pm 09/09/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.